UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
What psychedelics legalisation and decriminalisation looks like around the world
As of 2024, some psychedelics have been given a legal or decriminalised foothold in: parts of Central Africa (Equatorial Guinea, Cameroon and Republic of the Congo), South Africa, Australia, the Bahamas, Brazil, the British Virgin Islands, Canada, the Czech Republic, Costa Rica, Israel, Jamaica, Mexico, Nepal, the Netherlands, Panama, Peru, Portugal, Samoa, Spain, Switzerland and the United States.
UK parliament to discuss psilocybin rescheduling
A debate on ‘Psilocybin Access Rights’ will be heard in the House of Commons in mid-May.
Could MDMA’s UK approval be fast tracked by forthcoming Reciprocal Drug Approval Procedure with FDA?
Might MAPS PBC’s MDMA-assisted therapy for PTSD be among the first products considered under this new UK reciprocal drug approval pathway?
Experts' mixed responses to the surprise announcement of psilocybin & MDMA becoming (limitedly) licensed in Australia
The Australian Therapeutic Goods Administration has announced that psilocybin for treatment-resistant depression and MDMA for PTSD will be legally prescribable.
Schedule 1 barriers to research in the UK: An in-depth qualitative analysis
Findings highlight the challenges that Schedule 1 researchers are currently facing and suggest that the government should commission an urgent review
Boris Johnson apparently signed approval for rescheduling of psilocybin back in May!
Boris Johnson signed approval for the rescheduling of psilocybin, yet the Home Office fails to act.
Police officers will be able to hand out warnings for class A drug possession rather than seeking prosecution Scotland's Lord Advocate announces
Scottish police officers to issue warnings rather than prosecutions for personal possession of psychedelics
Two models of legalization of psychedelic substances: Reasons for concern
Two models of legalization of psychedelic substances